Our annual Fastest-Growing Private Companies tabulation has a company whose CEO wants to make sure "patients don't have to die on the waiting list anymore."

Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell Q™, a fully automated quality control testing platform purpose-built to match the commercial-scale throughput for cell therapy manufacturing. Cellares is unveiling these partnerships ahead of the 10th Annual CAR-TCR Summit, where it will, for the first time, present drug product release data automatically generated on the Cell Q and case studies highlighting the automation of system verification, thawing, assay preparation, and execution of vector copy number (VCN) quantification.

Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell Q™, a fully automated quality control testing platform purpose-built to match the commercial-scale throughput for cell therapy manufacturing. Cellares is unveiling these partnerships ahead of the 10th Annual CAR-TCR Summit, where it will, for the first time, present drug product release data automatically generated on the Cell Q and case studies highlighting the automation of system verification, thawing, assay preparation, and execution of vector copy number (VCN) quantification.

CBREはCellares社のアジア初となる再生医療製品の開発・製造拠点を柏市に支援。2027年開業予定のこの施設がもたらす影響とは？

New Kashiwa Integrated Development and Manufacturing Organization (IDMO) facility aims to boost CAR-T therapy access and cut manufacturing costs.

New Kashiwa Integrated Development and Manufacturing Organization (IDMO) facility aims to boost CAR-T therapy access and cut manufacturing costs.

再生医療の革新が柏の葉で加速する。Cellares社がアジアに初となる開発拠点を設立し、細胞治療薬の製造が容易に。これにより、日本の医療に新たな光が差し込む！

米国のCellares Corporationが柏市柏の葉にアジア初となる開発拠点を開設予定。オーダーメイド医療の進展が期待されます。

Integrated, automated facility will unlock next-generation, commercial-scale cell therapy manufacturing in Japan IDMO Smart Factory manufacturing capabilities will accelerate patient access for CAR-T and other cell therapies in the region SOUTH SAN FRANCISCO, Calif. & TOKYO–(BUSINESS WIRE)–Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, announces the establishment of Japan’s first …

The company noted that the AMT designation enables developers using this Cell Shuttle manufacturing platform to obtain expedited FDA review.

The company noted that the AMT designation enables developers using this Cell Shuttle manufacturing platform to obtain expedited FDA review.

The companies in a proof of concept automated the cellular drug substance manufacturing process for Cabaletta Bio’s CAR T-cell therapy candidate.

Why New Jersey is a hub for biotech manufacturing.

Why New Jersey is a hub for biotech manufacturing.

Groundbreaking automation success enables large-scale production of Cabaletta's rese-cel therapy across myositis, scleroderma, and lupus markets through smart factory network.